CDC Plans to Sell 32.34% Stake in Subsidiary, Extends Rights Offering

Overview

Chuong Duong Corp (CDC, HOSE) has approved the transfer of a 32.34% stake in its subsidiary Chuong Duong Homeland for at least VND 190 billion, and extended the timeline for a rights offering of nearly 52.8 million shares at VND 10,000 each to raise over VND 527.7 billion. The transactions are part of a broader capital restructuring effort.

Key Facts

• CDC plans to transfer 32.34% of Chuong Duong Homeland’s charter capital for no less than VND 190 billion.
• The transaction is expected to close before May 5, 2026, via negotiated method.
• CDC’s stake in Chuong Duong Homeland will decrease from 59.7% to 27.27% post-transfer.
• CDC is extending the rights offering of 52,788,000 shares at VND 10,000 per share, aiming to raise VND 527.7 billion.
• The rights offering ratio is 1:1, with the record date set for April 20, 2026.
• Proceeds from the rights offering will be used to repay loans, buy back bonds, and restructure short-term bank debt.
• If successful, CDC’s charter capital will increase from VND 527.7 billion to nearly VND 1,055.5 billion.
• CDC has also decided not to pay dividends from retained earnings of VND 45.7 billion as of December 31, 2025.

What Happened

Chuong Duong Corp (CDC) announced plans to sell a 32.34% stake in its subsidiary Chuong Duong Homeland, with a minimum price of VND 190 billion. The subsidiary has a charter capital of VND 555 billion, and CDC’s book value investment as of March 31, 2026, was VND 331.34 billion (59.7% stake). The sale will reduce CDC’s ownership to 27.27%.

Separately, CDC extended the timeline for its rights offering of 52.8 million shares at VND 10,000 each, originally scheduled to close earlier. The offering is part of a plan to raise over VND 527.7 billion to repay debts and restructure liabilities. The company also confirmed it will retain all after-tax profits from 2025 (VND 45.7 billion) for business operations rather than distributing dividends.

Market Context

CDC shares have faced pressure amid a sluggish real estate market in Vietnam. The company’s capital restructuring moves come as it seeks to improve its balance sheet. The rights offering, if fully subscribed, will significantly dilute existing shareholders but provide much-needed liquidity. CDC trades on HOSE and has a market capitalization of approximately VND 1.1 trillion as of the latest close.

Strategic Significance

The dual transactions indicate CDC is actively deleveraging and restructuring its capital structure. By selling a portion of its subsidiary, CDC reduces its exposure to Chuong Duong Homeland while raising cash. The rights offering, despite dilution, aims to strengthen the parent company’s financial position by reducing debt and improving working capital. This strategy is typical for Vietnamese real estate firms navigating tight credit conditions and slow property sales.

What to Watch

• Completion of the stake sale in Chuong Duong Homeland before the May 5, 2026 deadline.
• Subscription rate for the rights offering; low uptake could signal weak shareholder confidence.
• Use of proceeds: whether debt repayment materially improves CDC’s leverage ratios.
• Q2 2026 earnings report to assess the impact of capital restructuring on profitability.
• Any further asset sales or capital raising plans as part of the restructuring.